ロード中...

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy

INTRODUCTION: The classification of patients with prostate cancer is used to determine treatments based on risk factors. The presence of secondary circulating prostate tumour cells (CPCs) detected in peripheral blood after a curative treatment has been associated with a worse prognosis. We present a...

詳細記述

保存先:
書誌詳細
出版年:Ecancermedicalscience
主要な著者: Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Minzer, Simone, Salazar, Aníbal
フォーマット: Artigo
言語:Inglês
出版事項: Cancer Intelligence 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6027969/
https://ncbi.nlm.nih.gov/pubmed/30034521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.844
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!